A new, powerful Citizen Portal experience is ready. Switch now

Sponsor seeks locked‑case rule for kratom after state and national safety concerns

March 12, 2026 | 2026 Legislature RI, Rhode Island


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Sponsor seeks locked‑case rule for kratom after state and national safety concerns
Representative McGaugh told the House Committee on Corporations on March 12 that she will seek a requirement for kratom products to be stored in locked cases until purchase, citing public‑health concerns and data she said the state Department of Health provided.

"From 2020 to '24, there have been 10 fatal overdoses in Rhode Island that involved kratom," Representative McGaugh told the committee, saying she had contacted the Department of Health for information on overdoses and enforcement.

Opponents and industry witnesses said the record is more complex. Matt Caddo of the American Kratom Association said Rhode Island’s consumer‑protection rules from last year have not yet taken effect and warned against changing the law before the existing rules are implemented. He and other witnesses distinguished natural‑leaf kratom from chemically manipulated products (often referred to in testimony as "7‑OH" or "7‑hydroxymitragynine" or synthetic derivatives) and argued that many reported harms have involved adulterated or concentrated products rather than traditional leaf kratom.

Other lawmakers and witnesses urged technical clarity. Committee members asked McGaugh whether the 10 overdose deaths involved natural leaf kratom or adulterated products; she said she would follow up with the Department of Health for that level of detail. Several members and witnesses noted that other states (Utah, Connecticut, Ohio and others) have recently re‑examined or restricted kratom products.

The committee did not take a vote; members requested additional information from the Department of Health to determine whether the overdoses cited involved adulterated products or natural‑leaf formulations and to evaluate whether a locked‑case requirement is warranted.

Don't Miss a Word: See the Full Meeting!

Go beyond summaries. Unlock every video, transcript, and key insight with a Founder Membership.

Get instant access to full meeting videos
Search and clip any phrase from complete transcripts
Receive AI-powered summaries & custom alerts
Enjoy lifetime, unrestricted access to government data
Access Full Meeting

30-day money-back guarantee